Traité d'histoire légendaire et anecdotique, en prose et en vers, sans titre, ni nom d'auteur, rédigé, suivant ce qui est dit dans son introduction, d'après des livres analogues écrits en arabe.

Cet opuscule commence (folio 7 recto) par un résumé de la légende iranienne depuis Housheng ; vient ensuite celle des Sassanides (folio 12 verso), sous une forme encore plus sommaire ; celle de Mahomet et des khalifes (folio 16 recto), jusqu'à Mostaʿsim billah, le dernier vicaire du Prophète, qui fut mis à mort par Houlagou ; ensuite vient un chapitre, qui est donné comme le troisième de l'ouvrage (folio 26 recto), dans lequel se trouve une histoire fantaisiste du khalife Maʾmoun ; puis un chapitre donné comme le quatrième (folio 57 recto), qui expose une histoire romanesque du khalife. omayyade Valid II, fils de Yazid ; après quoi, vient un chapitre, qui serait le cinquième (folio 73 verso), dans lequel il est parlé des aventures extraordinaires qui survinrent au roi sassanide Shapour, fils d'Hormouz, à la cour de l'empereur grec, lesquelles forment une grande partie de ce recueil de légendes. On lit, à l'intérieur de l'un des plats de la reliure, le titre fantaisiste de تحفة المرتاض في التاريخ, avec cette glose que c'est une histoire des rois, contenant des anecdotes admirables et de très beaux enseignements. Manuscrit de luxe, orné d'un sarloh, enluminé en bleu et en or.

Aryl hydroxamic acid analogues as potential therapeutic agents /

A new synthetic pathway to analogues of the aglucones of naturally occurring cyclic hydroxamic acids (2,4-dihydroxy-l,4-benzoxazin-3-ones) has been developed. The new pathway involves the coupling of substituted nitrophenols wdth /-propyl-abromo- O-methoxymethylglycolate. These materials were reductively cyclised to reveal the hydroxamic acid functionality. Removal of the C-2 0-methoxymethyl protecting group was achieved chemoselectively using boron trichloride. The analogue 7-methoxy-2,4-dihydroxy-l,4-benzoxazin-3-one (DIMBOA) was assayed with papain and a semilog plot of activity of papain in the presence of excess DIMBOA was found to be linear. A single exponential equation was suggested as the model for kinetic analysis. '^ Nuclear magnetic resonance (NMR) spectra of a couple of hydroxamates were acquired as reference standards for future mechanistic studies of these compounds as thiol protease inhibitors. A 10% '^-labeled sample ofDIMBOA was also prepared for future mechanistic studies using NMR techniques.

Investigations towards the synthesis of isotope labelled analogues of tocopherols and tocotrienols /

Vitamin E is considered as the most effective lipophilic chain breaking antioxidant. a-Tocopherol and its analogues have been studied thoroughly with regards to its biokinetics and bioavailabily. Deuterated tocopherols have been synthesized and utilized in such studies. Tocotrienols are arousing more and more interest because of their high efficiency as antioxidants. However, to date, there is no effective synthetic method reported for deuterated tocotrienols. This thesis is focused on the investigation of the synthetic methods of deuterated tocotrienols and their analogues: 5-trideuteromethyl-a-tocotrienol, 5- trideuteromethyl-p-tocotrienol, tocotrienol acetate, silyl tocotrienol ether, etc. Several synthetic procedures for the preparation of poly-deuterated tocopherols are known. Mainly the deuterium is introduced by use of labelled formaldehyde and deuterated hydrogen chloride under Lewis acid catalysis. However, these methods are not effective in tocotrienols due to exchange of protons for deuterium at other sites under the acidic conditions. We developed several different approaches to generate polydeuterated tocotrienols by using both morpholinomethylation followed by reduction with NaCNBDs as deuterated reducing reagents and transmetalation strategy. The 5-trideuteromethyl-a-tocotrienol was finally obtained in a satisfactory yield of 60%. In addition, this thesis also discussed the study of structural comparison and the chemical property difference of tocopherols and tocotrienols, which provides hints to explain the reactivity difference of them towards oxidation at the C3-C4 positions.Furthermore, the methodology of halogenation and dehydrohalogenation of tocotrienol was explored to prepare a hexaene tocotrienol derivative as a florescent reporter of tocopherol.

Synthesis of fluorescent analogues of a-tocopherol as ligands for the human a-tocopherol transfer protein (a-TTP) /

To further understand in vivo localization and trafficking of a-tocopherol (a-Toe), the most biologically active form of vitamin E, between lipid environments, tocopherols are required that can be followed by teclu1iques such as confocal microscopy and fluorescence resonance energy transfer (FRET) assays. To this end, sixteen fluorescent analogues of a-tocopherol (la-d [(1)anthroy loxy -a-tocopherols, A O-a-Toes], 2a-d [w-nitro benzoxadiazole-a-tocopherols, NBD-aToes], 3a-d [w-dansyl-a-tocopherols, DAN-a-Toes], and 4a-d [w-N-methylanthranilamide-atocopherols, NMA-a-TocsD were prepared by substituting fluorescent labels at the terminus of w-functionalized alkyl chains extending from C-2 of the chroman ring while retaining key binding features of the natural ligand. These compounds were prepared starting from (S)-Trolox® acid VIa esterification, protection, and reduction producing the silyl-protected (S)-Trolox aldehyde that was coupled using Wittig chemistry to different w-hydroxyalkylphosphonium bromides. Reduction of the alkene generated the w-hydroxy functionalized 2-n-alkyl intermediates 9a-d having the necessary 2R stereochemistry. A series of functional group manipulations including mesylation, substitution with azide, and hydride reduction provided w-amino functionalized intermediates 12a-d as well. Coupling intermediates 9a-d and 12a-d with the selected fluorophores (9- anthracene carboxylic acid, 4-chloro-7-nitrobenz-2-oxa-l,3-diazole, 5- dimethylaminonapthalene-l-sulfonyl chloride, and I-methyl-2H-3,1-benzoxazine-2,4(1H)dione), followed by deprotection of the phenolic silyl group, gave the desired fluorescent ligands la-d, 2a-d, 3a-d and 4a-d in good yield. Assessment of their binding affinities with recombinant human a-tocopherol transfer protein (ha-TTP) utilizing fluorescent titration binding assays identified competent ligands for further use in protein studies. Compounds Id (C9-AO-a-Toc) and 2d (C9-NBD-a-Toc) both having nonyl alkyl chain extensions between the chromanol and fluorophore were shown to bind specifically to ha-TTP with dissociation constants (KdS) of approximately 280 nM and 55 nM respectively, as compared to 25 nM for the natural ligand 2R,4'R,^'R-a-tocophQxoL.

Chemoenzymatic synthesis of amaryllidaceae alkaloids and their C-1 analogues : symmetry based approach to total synthesis of thebaine

Described herein is the chemoenzymatic total synthesis of several Amaryllidaceae constituents and their unnatural C-I analogues. A new approach to pancratistatin and related compounds will be discussed along with the completed total synthesis of 7 -deoxypancratistatin and trans-dihydrolycoricidine. Evaluation of all new C-l analogues as cancer cell growth inhibitory agents is described. The enzymatic oxidation of dibromobenzenes by Escherichia coli 1M 109 (pDTG60 1) is presented along with conversion of their metabolites to (-)-conduritol E. Investigation into the steric and functional factors governing the enzymatic dihydroxylation of various benzoates by the same organism is also discussed. The synthetic utility of these metabolites is demonstrated through their conversion to pseudo-sugars, aminocyclitols, and complex bicyclic ring systems. The current work on the total synthesis of some morphine alkaloids is also presented. Highlighted will be the synthesis of several model systems related to the efficient total synthesis of thebaine.

SYNTHESIS OF CYCLIC AZOBENZENE ANALOGUES FOR INCORPORATION INTO OLIGONUCLEOTIDES, PEPTIDES AND POLYMERS

(A) In recent years, considerable amount of effort has contributed towards enhancing our understanding of the new photoswitch, cyclic azobenzene, particularly from the theoretical point of view. However, the challenging part with this system was poor efficiency of its synthesis from 2,2’- dinitrodibenzyl and lack of effective methods for further modification which would be useful to incorporate this system into biomolecules as a photoswitch. We report the synthesis of cyclic azobenzene and analogues from 2,2’-dinitrodibenzyl, which would allow for further incorporation of this cyclic azobenzene into biomolecules. Reaction of 2,2’-dinitrodibenzyl with zinc metal powder in the presence of triethylammonium formate buffer (pH-9.5) gave a cyclic azoxybenzene, 11,12-dihydrodibenzo[c,g][1,2]diazocine-5-oxide. The latter compound was converted into cyclic azobenzene analogues (bromo-, chloro-, cyano-, and carboxyl) through subsequent transformations. The carboxylic acid analogue was reacted with D-threoninol to give the corresponding amide, which readily undergoes photo-isomerization upon illumination with light. Upon illumination with light at 400 nm, approximately 70% of cis- isomer of amide was isomerized to trans- isomer. It was observed that cis- to trans- isomerization reached the maximum steady state of light transmission after approximately 40 min, whereas the trans- to cis- isomerization approximately acquired in 2 h to regain full recovery of light transmission. Cyclic azobenzene phosphoramidite was synthesized from DMT-protected D-threoninol linked cyclic azobenzene. (B) In recent years, there has been considerable interest invested towards the synthesis of azobenzene analogues for incorporation into proteins. Among the many azobenzene analogues, the synthesis of bi-functional cyclic azobenzene analogues for the incorporation into proteins is relatively new. In this thesis, we report the synthesis of a cyclic azobenzene biscarboxylic acid from 4-(bromomethyl)benzonitrile. (C) Azobenzene has been widely used in the field of polymer science to study the surface morphology and surface properties of polymers. In this thesis, we report the incorporation of cyclic azobenzene into a commercial polymer 2- (hydroxyethyl)methacrylate. Samples collected after 24 h from the reaction solution showed approximately 9% of incorporation of cyclic azobenzene into polymer compared to samples collected after 10 h, which showed approximately 6% incorporation.

Synthesis of unnatural analogues of pancratistatin and narciclasine

Described herein is the chemoenzymatic synthesis of several different types of unnatural analogues of Amaryllidaceae constituents. Development and refinement of existing and design and execution of new approaches towards the synthesis of C-1 analogues of pancratistatin and A-ring heterocyclic analogues of narciclasine are discussed. Evaluation of the new analogues as cancer growth inhibitory agents is also described

Synthesis of 3', 5'-cyclic diguanylic acid (c-di-GMP) analogues

In the past few years, interest in signaling networks involving 3ʹ, 5ʹ -cyclic diguanylic acid (c-di-GMP) has increased dramatically. Evidence started to emerge that connects c-di-GMP to the regulation of a range of biological processes in bacteria, such as bacterial biofilm formation, virulence, extracellular polysaccharide synthesis, however, much remains to be explored in the signaling pathways that involve this secondary messenger. This molecule has also been shown to be a very powerful immunostimulating agent and potent mucosal vaccine adjuvant.

Approach to the Synthesis of Aza-Analogues of Narciclasine through an Intramolecular Heck Reaction

This thesis describes work towards the total synthesis of a 7-aza analogue of the Amaryllidaceae alkaloid narciclasine, a potent anticancer compound which suffers from a poor solubility profile. A key strategy in the formation of the C-ring is the biotransformation of bromobenzene by E.coli JM109. The densely substituted heterocyclic A-ring is obtained by sequential directed ortho-metalation and the fragment union accomplished with an amide coupling and subsequent intramolecular Heck reaction.

Régulation de l'activité transcriptionnelle de PPARgamma via l'activation des récepteurs CD36 et GHS-R1a : potentiel anti-athérosclérotique

Les sécrétines peptidiques de l’hormone de croissance (GHRPs) constituent une classe de peptides synthétiques capables de stimuler la sécrétion de l’hormone de croissance (GH). Cette activité est médiée par leur liaison à un récepteur couplé aux protéines G : le récepteur des sécrétines de l’hormone de croissance (GHS-R1a), identifié subséquemment comme le récepteur de la ghréline. La ghréline est un peptide de 28 acides aminés sécrété principalement par les cellules de la muqueuse de l’estomac, qui exerce de nombreux effets périphériques indépendamment de la sécrétion de l’hormone de croissance. Les effets indépendants de la sécrétion de GH incluent, entre autres, des actions sur le contrôle de la prise de nourriture, le métabolisme énergétique, la fonction cardiaque, le système immunitaire et la prolifération cellulaire. L’étude de la distribution périphérique des sites de liaison des GHRPs nous a permis d’identifier un second site, le CD36, un récepteur scavenger exprimé dans plusieurs tissus dont le myocarde, l’endothélium de la microvasculature et les monocytes/macrophages. Le CD36 exprimé à la surface du macrophage joue un rôle clé dans l’initiation du développement de l’athérosclérose par la liaison et l’internalisation des lipoprotéines de faible densité oxydées (LDLox) dans l’espace sous-endothélial de l’artère. L’hexaréline, un analogue GHRP, a été développé comme agent thérapeutique pour stimuler la sécrétion de l’hormone de croissance par l’hypophyse. Sa propriété de liaison aux récepteurs GHS-R1a et CD36 situés en périphérie et particulièrement sa capacité d’interférer avec la liaison des LDLox par le CD36 nous ont incité à évaluer la capacité de l’hexaréline à moduler le métabolisme lipidique du macrophage. L’objectif principal de ce projet a été de déterminer les effets de l’activation des récepteurs CD36 et GHS-R1a, par l’hexaréline et la ghréline, le ligand endogène du GHS-R1a, sur la physiologie du macrophage et de déterminer son potentiel anti-athérosclérotique. Les résultats montrent premièrement que l’hexaréline et la ghréline augmentent l’expression des transporteurs ABCA1 et ABCG1, impliqués dans le transport inverse du cholestérol, via un mécanisme contrôlé par le récepteur nucléaire PPARγ. La régulation de l’activité transcriptionnelle de PPARγ par l’activation des récepteurs CD36 et GHS-R1a se fait indépendamment de la présence du domaine de liaison du ligand (LBD) de PPARγ et est conséquente de changements dans l’état de phosphorylation de PPARγ. Une étude plus approfondie de la signalisation résultant de la liaison de la ghréline sur le GHS-R1a révèle que PPARγ est activé par un mécanisme de concertation entre les voies de signalisation Gαq/PI3-K/Akt et Fyn/Dok-1/ERK au niveau du macrophage. Le rôle de PPARγ dans la régulation du métabolisme lipidique par l’hexaréline a été démontré par l’utilisation de macrophages de souris hétérozygotes pour le gène de Ppar gamma, qui présentent une forte diminution de l’activation des gènes de la cascade métabolique PPARγ-LXRα-transporteurs ABC en réponse à l’hexaréline. L’injection quotidienne d’hexaréline à un modèle de souris prédisposées au développement de l’athérosclérose, les souris déficientes en apoE sous une diète riche en cholestérol et en lipides, se traduit également en une diminution significative de la présence de lésions athérosclérotiques correspondant à une augmentation de l’expression des gènes cibles de PPARγ et LXRα dans les macrophages péritonéaux provenant des animaux traités à l’hexaréline. L’ensemble des résultats obtenus dans cette thèse identifie certains nouveaux mécanismes impliqués dans la régulation de PPARγ et du métabolisme du cholestérol dans le macrophage via les récepteurs CD36 et GHS-R1a. Ils pourraient servir de cibles thérapeutiques dans une perspective de traitement des maladies cardiovasculaires.